Optimisation of insulin treatment to improve cardiovascular risk
De Leiva, A.
International Journal of Clinical Practice. Suppl 107: 11-13
1999
ISSN/ISBN: 1368-504X PMID: 10692726 Document Number: 511850
Document emailed within 1 workday
Related Documents
Fang, F.-s.; Tian, H.; Li, C.-l.; Yan, S.-t.; Miao, X.-y.; Cheng, X.-l. 2011: Comparison of postprandial insulin and fasting insulin on the evaluation of cardiovascular risk factors Zhonghua Yi Xue Za Zhi 91(14): 946-949Ametov, A.S.; Kochergina, I.I.; Ulanova, K.A. 2010: Effect of insulin therapy on insulin resistance and risk for ischemic heart disease and death from cardiovascular pathology in patients with diabetes mellitus, type 2 Terapevticheskii Arkhiv 82(3): 42-46
Guo, D.; Xu, C. 1997: The role of insulin resistance in the clustering of cardiovascular risk factors Zhonghua Nei Ke Za Zhi 36(4): 250-252
Bosch, V.M.; Gutiérrez, J.D.; Solano, C.; de la Torre, G.; Espejo, P.; Meca, J.; Contreras, J. 1993: Insulin resistance as cardiovascular risk factor in childhood and adolescence Anales Espanoles de Pediatria 39(Suppl 55): 153-156
Roos, A.N.; Meinders, A.E. 1989: Does an insulin pen improve the metabolic control of type 1 diabetes mellitus if added to conventional treatment? Netherlands Journal of Medicine 34(3-4): 116-125
Greenfield, J.R.; Samaras, K.; Chisholm, D.J. 2002: Insulin resistance, intra-abdominal fat, cardiovascular risk factors, and androgens in healthy young women with type 1 diabetes mellitus Journal of Clinical Endocrinology and Metabolism 87(3): 1036-1040
Tonstad, S. 1998: Should treatment of risk factors of cardiovascular diseases be directed only by absolute risk? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 118(19): 2966-2968
Kleber, M.E.; Winkler, K.; Wolfert, R.L.; Delgado, G. de Moissl; Grammer, T.B.; Dietz, S.; Winkelmann, B.R.; Boehm, B.O.; Winfried März 2011: Lipoprotein Associated Phospholipase A2 Concentration Predicts Total and Cardiovascular Mortality Independently of Established Risk Factors (The Ludwigshafen Risk and Cardiovascular Health Study) Clinical Laboratory 57(9-10): 659-667
Baena Díez, Jé.Miguel.; Del Val García, Jé.Luis.; Alemany Vilches, L.; Martínez Martínez, Jé.Luis.; Tomàs Pelegrina, J.; González Tejón, Ián.; Raidó Quintana, E.María.; Rovira España, Mónica. 2005: Risk of Suffering from Cardiovascular Diseases because of the Clustering of the Modifiable Cardiovascular Risk Factors in the Population Older than 15 years of a Health Care Center in Barcelona Revista espanola de salud publica 79: 365-378
Hamaguchi, T.; Sadahiro, K.; Satoh, T. 2015: Current concept of insulin therapy intensification, and the role of human regular insulin and rapid-acting insulin analogs in insulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 447-452
Osler, M.; Jespersen, N.B.; Lous, J.; Rasmussen, N.K. 1992: Cardiovascular risk factors--extent and self-assessed risk in relation to prevention of cardiovascular diseases. A questionnaire among 3,956 men and women aged 24-65 years in Vejle County, Slangerup and Helsinge municipalities Ugeskrift for Laeger 154(9): 538-543
Costello, M.; Shrestha, B.; Eden, J.; Sjoblom, P.; Johnson, N. 2007: Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome Cochrane Database of Systematic Reviews 1: Cd005552
Białecka, M.; Adamiak, U.; Gawrońska-Szklarz, B. 2009: Optimisation of treatment of Parkinson's disease with levodopa Neurologia i Neurochirurgia Polska 43(5): 446-459
Grossmann, D.; Köser, H.; Kretschmer, R.; Porobin, M. 2001: Treatment of diglyme containing wastewater by advanced oxidation--process design and optimisation Water Science and Technology: a Journal of the International Association on Water Pollution Research 44(5): 287-293
Vigna, G.Battista.; Fellin, R. 2003: Dyslipidemia and global cardiovascular risk: treatment guidelines Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 4 Suppl. 7: 4s
Kannel, W.B. 1996: Blood pressure as a cardiovascular risk factor: prevention and treatment JAMA 275(20): 1571-1576
Moulin, P.; Sérusclat, Aé.; Bernard, S. 2005: Cardiovascular prevention of high risk patients by hypolipidemic treatment La Revue du Praticien 55(16): 1783-1787
Samushiia, O.S.; Beraia, M.V.; Iashvili, N.S.; Batiashvili, D.S.; Tugushi, M.V. 2006: Optimisation issues of conservative treatment of neurological abnormalities in dystrophyc-degeneration processes of the vertebral column Georgian Medical News 132: 57-60
Rasić, S.; Kulenović, I.; Uncanin, S. 2005: Parathormone as a cardiovascular risk factor in uraemic patients on haemodialysis treatment Medicinski Arhiv 59(4): 231-234
Palmieri, L.; Trojani, M.; Vanuzzo, D.; Panico, S.; Pilotto, L.; Dima, F.; Noce, C.L.; Uguccioni, M.; Pede, S.; Giampaoli, S. 2005: Distribution of the global cardiovascular risk in the Italian population: results from the cardiovascular epidemiologic observatory Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 6(5): 279-284